𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas

✍ Scribed by Mark M. Zalupski; Jacqueline Benedetti; Stanley P. Balcerzak; Laura F. Hutchins; Robert J. Belt; Alexander Hantel; John Wendall Goodwin

Publisher
Springer US
Year
1993
Tongue
English
Weight
390 KB
Volume
11
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of echinomycin in advance
Phase II trial of echinomycin in advanced soft tissue sarcomas
✍ Sarah A. Taylor; Barbara Metch; Stanley P. Balcerzak; Karl H. Hanson πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 232 KB

Thirty-four patients with advanced soft tissue sarcomas were entered in a phase II trial of echinomycin. Patients received 1.2 mg/m 2 intravenously (i.v.) weekly times four followed by a two week rest period. There were no objective responses. Dose limiting toxicity was gastrointestinal. Echinomycin

A phase II trial of temozolomide in pati
A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma
✍ Susan M. Talbot; Mary Louise Keohan; Mary Hesdorffer; Russell Orrico; Emilia Bag πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 3 views

## Abstract ## BACKGROUND The objective of this study was to assess the efficacy and toxicity of the imidazotetrazine derivative temozolomide for patients with unresectable or metastatic soft tissue sarcoma. ## METHODS Twenty‐five of 26 patients were eligible and assessable for toxicity and resp